References
- Arora, M., et al., 2016. Late acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biology of blood and marrow transplant, 22 (3), 449–455.
- Atiq, F., et al., 2018. Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals. European journal of clinical pharmacology, 74 (6), 767–773.
- Chen, X., et al., 2012. Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6. PLOS one, 7 (6), e38495.
- Ciurea, S.O., et al., 2019. Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation? Blood, 134 (Supplement_1), 42–42.
- Cvetkovic, M., et al., 2017. Effect of age and allele variants of CYP3A5, CYP3A4, and POR genes on the pharmacokinetics of cyclosporin A in pediatric renal transplant recipients from Serbia. Therapeutic drug monitoring, 39 (6), 589–595.
- Elens, L., et al., 2014. Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients. Therapeutic drug monitoring, 36 (1), 1.
- Gu, X., et al., 2006. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. Journal of biological chemistry., 281 (26), 17882–17889.
- Hesselink, D.A., et al., 2008. A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine. Pharmacogenomics, 9 (6), 783–789.
- Hu, Y.F., et al., 2007. Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects. Xenobiotica, 37 (3), 315–327.
- Huang, B., et al., 2020. Comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis after allogeneic hematopoietic cell transplantation. Transplantation, 104 (2), 428–436.
- Jordán De Luna, C., et al., 2011. Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels. Transplantation proceedings, 43 (6), 2241–2243.
- Lunde, I., et al., 2014. The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. European journal of clinical pharmacology, 70 (6), 685–693.
- McCune, J.S., and Bemer, M.J., 2016. Pharmacokinetics, pharmacodynamics and pharmacogenomics of immunosuppressants in allogeneic haematopoietic cell transplantation: part I. Clinical pharmacokinetics., 55 (5), 525–550.
- Oleson, L., et al., 2010. Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism. Xenobiotica, 40 (2), 146–162.
- Qiu, X.Y., et al., 2008. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients. European journal of clinical pharmacology, 64 (11), 1069–1084.
- Satwani, P., et al., 2017. A multicenter study of bacterial blood stream infections in pediatric allogeneic hematopoietic cell transplantation recipients: the role of acute gastrointestinal graft-versus-host disease. Biology of blood and marrow transplantation, 23 (4), 642–647.
- Schirmer, M., et al., 2007. Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes. Pharmacogenomics, 8 (5), 443–453.
- Sefidgar, M., et al., 2014. Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors. Journal of biological engineering., 8, 12.
- Shao, B., et al., 2018. Vitamin D pathway gene polymorphisms influenced vitamin D level among pregnant women. Clinical nutrition, 37 (6), 2230–2237.
- Sharaki, O., et al., 2015. Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients. Molecular biology reports, 42 (1), 105–117.
- Stocker, N., et al., 2019. Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation. European journal of haematology, 103 (1), 10–17.
- Sun, B., et al., 2017. Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients. Pharmacogenomics, 18 (16), 1503–1513.
- Wang, P., et al., 2015. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Epilepsy research, 117, 52–57.
- Zhang, Y., et al., 2013. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients. ACTA Pharmacologica Sinica., 34 (4), 555–560.
- Zhou, Q., et al., 2005. Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. British journal of clinical pharmacology, 59 (4), 415–424.